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Abstract 1: 10th Palliative Care Congress 
 
Title: Patient and Public involvement in scope development for a palliative care Health 
Technology Assessment: a European perspective.  
 
Background: Patient and Public Involvement (PPI) helps to ensure that study findings are 
useful to end users but is under-developed in Health Technology Assessment (HTA).  
"INTEGRATE-HTA, (co-funded European Union project -grant agreement 30614) is 
developing new methods to assess complex health technologies and applying these in a 
palliative care case study. Having experienced the intended and unintended consequences of 
palliative care services, which vary widely across Europe, patients in six countries (England, 
Germany, Italy, Netherlands, Norway and Poland) provided valuable insights and advice. 
 
Aims: To establish PPI in a palliative care HTA.   
 
Methods: As PPI to assist early scope development in HTA is novel, each country  
implemented PPI methods as appropriate locally either using a qualitative research approach 
or seeking the views of patients, relatives or patient representatives as research partners.  
Using a qualitative approach, 21 individual, face-face patient interviews were conducted and 
analysed thematically. When patients were research partners, an adapted version of the 
EUnetHTA core model guided 30 face-face discussions. Thematic analysis and conceptual 
mapping were used to identify key issues. 
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Findings: PPI requires researchers to have cultural awareness of palliative care and the 
acceptability of engaging in discussions around dying in each country.  Ensuring positive PPI 
experiences and effective participation by acknowledging patient knowledge, experience and 
establishing a two-way flow of information in the HTA process is essential. Partnership 
working between researchers and patients, stakeholder evaluation and remuneration when 
involved as partners is important.  
 
Conclusions: PPI assisted patient-centred scope development and identification of important 
issues related to palliative care in each country.  Methods of PPI engagement require further 
development. None-the-less, all PPI methods have advantages and limitations which must be 
considered in light of local needs, resources and culture.  
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